Which drugs does patent 5,420,319 protect, and when does it expire?
Patent 5,420,319 protects ELOXATIN and is included in two NDAs. There have been four Paragraph IV challenges on Eloxatin.
Protection for ELOXATIN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has five patent family members in four countries.